Enovix financials
$2.75+7.63%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 28 | FY24 Dec 29 | FY23 Dec 31 | FY22 Jan 1 | FY21 Jan 2 |
|---|---|---|---|---|---|
| Revenue | $31.8M | $23.1M | $7.6M | $6.2M | $0.00 |
| Gross profit | $6.1M | -$2.0M | -$55.4M | -$17.0M | -$2.0M |
| Gross margin | 19.2% | −8.9% | −725.0% | −274.7% | — |
| Operating income | -$177.3M | -$242.7M | -$230.3M | -$132.0M | -$69.5M |
| Net income | -$156.7M | -$222.2M | -$214.1M | -$51.6M | -$125.9M |
| Net margin | −492.6% | −963.2% | −2800.5% | −832.3% | — |
| Diluted EPS | $-0.75 | $-1.19 | $-1.30 | $-0.72 | $-0.94 |
| EBITDA | -$142.1M | -$155.9M | -$188.8M | -$119.1M | -$68.0M |
| Operating cash flow | -$95.3M | -$108.6M | -$104.6M | -$82.7M | -$51.3M |
| Free cash flow | -$113.5M | -$184.8M | -$166.4M | -$119.0M | -$94.9M |
| Diluted shares | 207.6M | 186.0M | 169.6M | 176.2M | 134.0M |
Balance sheet
| Period end | Dec 28 | Dec 29 | Dec 31 | Jan 1 | Jan 2 |
|---|---|---|---|---|---|
| Cash & equivalents | $106.0M | $272.9M | $233.1M | $322.9M | $385.3M |
| Short-term investments | $406.0M | $0.00 | $73.7M | $0.00 | — |
| Total debt | $529.1M | $179.3M | $175.0M | $0.00 | $0.00 |
| Total assets | $879.0M | $527.2M | $564.3M | $440.6M | $482.6M |
| Total liabilities | $605.0M | $277.8M | $260.3M | $35.1M | $32.2M |
| Shareholders' equity | $274.0M | $249.4M | $304.0M | $405.5M | $450.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology